- Home
- VRA vs BRNS Comparison
VRA vs BRNS Comparison
Compare VRA & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRA
- BRNS
- Stock Information
- Founded
- VRA 1982
- BRNS 2016
- Country
- VRA United States
- BRNS United Kingdom
- Employees
- VRA N/A
- BRNS N/A
- Industry
- VRA Apparel
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- VRA Consumer Discretionary
- BRNS Health Care
- Exchange
- VRA Nasdaq
- BRNS Nasdaq
- Market Cap
- VRA 60.6M
- BRNS 55.9M
- IPO Year
- VRA 2010
- BRNS 2021
- Fundamental
- Price
- VRA $2.64
- BRNS $0.79
- Analyst Decision
- VRA Buy
- BRNS Strong Buy
- Analyst Count
- VRA 3
- BRNS 1
- Target Price
- VRA $4.00
- BRNS $3.00
- AVG Volume (30 Days)
- VRA 285.5K
- BRNS 109.6K
- Earning Date
- VRA 12-10-2025
- BRNS 11-07-2025
- Dividend Yield
- VRA N/A
- BRNS N/A
- EPS Growth
- VRA N/A
- BRNS N/A
- EPS
- VRA N/A
- BRNS N/A
- Revenue
- VRA $332,526,000.00
- BRNS N/A
- Revenue This Year
- VRA N/A
- BRNS N/A
- Revenue Next Year
- VRA $2.33
- BRNS N/A
- P/E Ratio
- VRA N/A
- BRNS N/A
- Revenue Growth
- VRA N/A
- BRNS 1766.46
- 52 Week Low
- VRA $1.71
- BRNS $0.64
- 52 Week High
- VRA $5.99
- BRNS $2.92
- Technical
- Relative Strength Index (RSI)
- VRA 63.79
- BRNS 27.25
- Support Level
- VRA $2.29
- BRNS $0.75
- Resistance Level
- VRA $2.79
- BRNS $1.25
- Average True Range (ATR)
- VRA 0.21
- BRNS 0.12
- MACD
- VRA 0.03
- BRNS -0.05
- Stochastic Oscillator
- VRA 71.21
- BRNS 8.93
About VRA Vera Bradley Inc.
Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.